PGA

PGA
Name	Polyglycolic acid
Other names	Poly(glycolic acid); PGA
Formula	(C2H2O2)n
Molar mass	58.04 g·mol−1 (repeat unit)
Appearance	White crystalline solid
Melting point	~225–230 °C (decomposes)
Density	~1.5 g·cm−3
Solubility	Hydrolytically degradable; soluble in certain aprotic solvents
Uses	Surgical sutures, biodegradable plastics, drug delivery

PGA

Polyglycolic acid is a synthetic aliphatic polyester used in biodegradable materials, medical devices, and industrial resins. It combines high crystallinity and tensile strength with rapid hydrolytic degradation, making it important for surgical sutures, implantable devices, and controlled-release carriers. PGA’s properties have driven research in polymer chemistry, biomaterials, and toxicology across academic and industrial institutions.

Definition and Overview

Polyglycolic acid is a linear polyester formed from the ring-opening polymerization of glycolide or by polycondensation of glycolic acid, producing a high-melting, crystalline polymer. Major manufacturers and developers in the field include Eli Lilly and Company, Johnson & Johnson, Bayer AG, and academic groups at Massachusetts Institute of Technology, Stanford University, and Imperial College London. PGA is structurally related to other aliphatic polyesters such as polylactic acid and polycaprolactone, and it participates in commercial and clinical applications alongside materials from companies like Stryker Corporation and Medtronic plc.

History and Development

Early synthetic polyester research in the 20th century by chemists at institutions like DuPont and BASF set groundwork for biodegradable polymers. Ring-opening polymerization techniques advanced in laboratories at University of Tokyo and ETH Zurich enabled higher-molecular-weight PGA suitable for medical uses. The first clinical adoption for absorbable sutures occurred following trials involving surgeons at Johns Hopkins Hospital and regulatory approval processes with agencies such as the United States Food and Drug Administration and the European Medicines Agency. Industry collaborations with companies including Ethicon and research funded by foundations like the Wellcome Trust further accelerated translation.

Types and Variants

Commercial grades vary by molecular weight, end-group chemistry, and copolymer composition. Copolymers combine glycolide with monomers from lactic acid to form copolymers marketed by firms such as B. Braun Melsungen AG and Poly-Med, Inc. for tuned degradation. Block and random copolymers incorporating caprolactone or trimethylene carbonate provide variants used by manufacturers like Smith & Nephew and research groups at University of California, Berkeley. Sterilization-tolerant formulations have been developed for devices produced by Zimmer Biomet and implantable systems studied at Harvard Medical School.

Manufacturing and Chemical Properties

Industrial production uses ring-opening polymerization of cyclic dimers (glycolide) with catalysts derived from metal acetates or organometallic initiators, techniques developed in labs at Rensselaer Polytechnic Institute and California Institute of Technology. The polymer exhibits high crystallinity, a glass transition temperature below physiological temperature, and hydrolytic ester cleavage that yields glycolic acid, a metabolite processed via pathways involving enzymes in liver tissue and mitochondria. Analytical characterization employs techniques from American Chemical Society-standardized methods: gel permeation chromatography used by labs at National Institute of Standards and Technology, differential scanning calorimetry from Thermo Fisher Scientific equipment, and nuclear magnetic resonance pioneered at Bruker facilities.

Applications and Uses

Medical applications include absorbable sutures, orthopedic pins, and scaffolds for tissue engineering developed by groups at Cleveland Clinic and companies like Integra LifeSciences. Drug-delivery implants using PGA matrices have been investigated in clinical trials at Mayo Clinic and by pharmaceutical firms such as AbbVie. In packaging, blends with polyesters from Toyota Industries Corporation and Dow Chemical Company aim to produce biodegradable films and fibers. Research collaborations with National Institutes of Health and engineering teams at Ohio State University explore PGA-based scaffolds for regenerative medicine and combination products with devices from Boston Scientific.

Environmental and Safety Considerations

PGA degrades hydrolytically to glycolic acid, which enters metabolic pathways and is further oxidized to carbon dioxide and water; environmental fate studies have been conducted by agencies like Environmental Protection Agency and academic groups at University of Cambridge. Occupational exposure controls follow standards recommended by organizations such as Occupational Safety and Health Administration. Biocompatibility testing aligns with guidance from International Organization for Standardization and American Society for Testing and Materials, while post-market surveillance for medical devices often involves reporting to the United States Food and Drug Administration and healthcare institutions like Cleveland Clinic.

Regulation and Standards

Medical and consumer products containing PGA are regulated through frameworks administered by the United States Food and Drug Administration, the European Medicines Agency, and national agencies such as Pharmaceuticals and Medical Devices Agency in Japan. Standards for testing and quality control are provided by organizations including International Organization for Standardization (ISO 10993 series), American Society for Testing and Materials (ASTM F series), and guidance documents from World Health Organization for sterility and safety assessment. Manufacturers such as Ethicon and B. Braun Melsungen AG comply with regulatory submissions and quality systems aligned with Food and Drug Administration and European Commission directives.

Category:Polymers